BlueRock Therapeutics

📍 Cambridge, United States🗓 Founded 2016👥 457 employees💰 Last funded Dec 2016
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in BlueRock Therapeutics?
BlueRock Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did BlueRock Therapeutics last raise funding?
The most recent investment in BlueRock Therapeutics recorded on gritt.io was in December 2016.
When was BlueRock Therapeutics founded?
BlueRock Therapeutics was founded in 2016.
What industry is BlueRock Therapeutics in?
BlueRock Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BlueRock Therapeutics based?
BlueRock Therapeutics is headquartered in Cambridge, United States.